Series D · Biotech · Leuven, Belgium · Founded 2015 · 69–75 employees
Since its 2015 spin-out from imec and a research collaboration with Johns Hopkins University, **miDiagnostics** has pioneered silicon-chip and nanofluidic PCR technology that brings ultra-rapid, lab-quality molecular testing out of centralized labs and closer to patients and clinicians; headquartered in Leuven, the company’s platform enables high-precision biomarker analysis from minimal samples for infection screening, monitoring and emerging sterility assays, and in 2024 it secured a €30 M **Series D** led by Thermo Fisher Scientific to accelerate commercialisation of next-generation diagnostics for biopharma, healthcare and decentralized care settings.
No open roles listed right now.